Clinical trial
BIOTRONIK - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)
NCT01661231 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIOTRONIK - The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe)
- Lead sponsor
- Biotronik AG
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2012
- Completion date
- October 31, 2018
- Enrollment
- 456 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease, peripheral vascular disease